|
|
FDADocs 5/12/2008 | 0 (0) | 17 | 0 | 0 | English
Drug Development for Resistant Pathogens-PhRMA Antibiotics Working GroupFrancis P. Tally MD Cubist Pharmaceuticals, Inc. November 19, 2002Antimicrobial Resistance in Nosoc... ... more>>
FDADocs 5/12/2008 | 0 (0) | 22 | 0 | 0 | English
Exposure-Response: Application to Antimicrobial Drug DevelopmentIDSA/PhRMA/FDA Workshop November... Pharmacology and Biopharmaceutics IDSA/PhRMA/FDA Workshop 11/19/02Guidances: Exposure-Response (E-R ... more>>
FDADocs 5/12/2008 | 0 (0) | 35 | 0 | 0 | English
FDA Experience and Perspective on Non-Inferiority TrialsRobert J. Temple, M.D. Associate Director for Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug AdministrationFDA ... more>>
FDADocs 5/12/2008 | 0 (0) | 51 | 0 | 0 | English
Hepatotoxicity Steering Committee Contact Sheet Revised February 2006NAME Mark Avigan FDA Jeffrey... Cirangle Consultant Joe DeGeorge Merck Tricia Desantis Johnson & Johnson Yvonne Dragan FDA/NCTR ... more>>
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
Issues??and??Controversies??in??DILI?? Session??I:????FDA??Concept??Paper???????Premarketing...?? UNC?? GSK?? FDA?? FDA?? PhRMA??Session??1.1?? Drafting??of??Concept??Paper:????Premarketing ... more>>
FDADocs 5/12/2008 | 0 (0) | 15 | 0 | 0 | English
://www.fda.gov/cber/guidelines.htm. For questions on the content of this guidance, contact the ... more>>
FDADocs 5/12/2008 | 0 (0) | 12 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 15 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 13 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 14 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 14 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
CALL FOR ABSTRACTS Poster Session on Genomics and Proteomics10TH Annual FDA Science ForumFDA Science: The Critical Path from Concept to ConsumerMay 18-19, 2004, Washington Convention Center ... more>>
FDADocs 5/12/2008 | 0 (0) | 24 | 2 | 0 | English
SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he... ... more>>
FDADocs 5/12/2008 | 0 (0) | 12 | 0 | 0 | English
FDA Flawed Gate keepingTestimony Vera Sharav President Alliance for Human Research Protection... intervention.???FDA Prozac Safety Review, 1990???The data showed higher percentages of suicidality ... more>>
FDADocs 5/12/2008 | 0 (0) | 22 | 0 | 0 | English
FDA Public Hearing Regarding Medication Guide Program ReformJune 12, 2007Steve Heidenthal, R.Ph. CVS Caremark Corporation-0-CVS Caremark BackgroundIntegrated pharmacy services ... more>>
| | | |
| results / page 15/25/50 |
Page: 2 of 33
|
2...
|
|